Pain outcomes (WOMAC pain score): Additional findings: Systolic blood pressure reduced by 14 mmHg at 12 mg Improved non-HDL cholesterol, triglycerides, and hsCRP (a marker of inflammation) New safety signal -- dysesthesia: Dysesthesia (abnormal sensations such as burning, tingling, or numbness) emerged as a new adverse event in this trial: 8.8% at 9 mg 20.9% at 12 mg 0.7% at placebo TRIUMPH-5 -- Head-to-Head vs Tirzepatide TRIUMPH-5 is a Phase 3 head-to-head efficacy trial comparing retatrutide to tirzepatide in adults with obesity
& Han, J
Cost-Effectiveness and Scalability : Nanoparticles and antioxidants face high production costs due to complex processes, scalability issues, limited access in resource-poor settings, and economic viability
Sleep quality changes during treatment While the long-term trajectory is typically positive for sleep, the short-term experience can be more variable
France Studies in chicken embryos suggest that BPC 157 stimulates vascular development by activating VEGFR2, a cell surface receptor involved in nitric oxide signalling
Cream, though, are typically intended for those struggling with distressing sexual symptoms
